Accelerated Recovery After MIS Hepatectomy (ARAMIS Hep) to Support Early Discharge for Patients Undergoing Minimally Invasive Liver Resection

StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing
    • Enrollment target: estimated 36 to confirmed 39
    • Eligibility criteria expanded, about 14 words
    • Site details revised
  2. 3 versions Re-verified since Oct 23, 2025, no change to tracked fieldsv8-v10
  3. Primary completion date: Feb 1, 2025 to Feb 1, 2027
    • Site contact updated
    v7
  4. Site contact updatedv6
  5. Re-verified, no change to tracked fieldsv5
Show 3 earlier versionsHide 3 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 30, 2023 to Oct 5, 2023
    • Site details revised
    v4
  2. Re-verified, no change to tracked fieldsv3
  3. Study arms: 1 to 2v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To learn if an accelerated recovery program can shorten the length of hospital stay in patients having minimally invasive liver surgery.
Trial Details
NCT Number NCT05879159
Lead Sponsor M.D. Anderson Cancer Center
Collaborators: Intuitive Surgical
Conditions
(from sponsor)		 Liver
Enrollment 39 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov